Osteoarthritis pain mechanisms: Basic studies in animal models

Osteoarthritis and Cartilage

Volumn 21, Issue 9, 2013, Pages 1308-1315

  Zhang, R X ^a   Ren, K ^b   Dubner, R ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Allodynia; Hyperalgesia; Monoiodoacetate; Osteoarthritis; Pain; Spinal cord

Indexed keywords

1 (2,3 DICHLOROBENZOYL) 5 METHOXY 2 METHYL 3 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID; CAPSAICIN; CELECOXIB; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DICLOFENAC; ENDOCANNABINOID; ENDORPHIN; ETANERCEPT; EUGENOL; GABAPENTIN; GLYCOPROTEIN; INTERLEUKIN 6; IODOACETIC ACID; LIDOCAINE; METALLOPROTEINASE; MINOCYCLINE; MORPHINE; NALOXONE; NEUROPEPTIDE; NIMESULIDE; OPIATE ANTAGONIST; REBAMIPIDE; SEROTONIN; SEROTONIN 3 RECEPTOR; TRAMADOL; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VANILLOID RECEPTOR 1; ZOLEDRONIC ACID;

ALLODYNIA; ARTHRALGIA; ARTICLE; AVERSIVE BEHAVIOR; BODY WEIGHT; BRAIN FUNCTION; CALCIUM CELL LEVEL; CARTILAGE CELL; HUMAN; NONHUMAN; OSTEOARTHRITIS; PAIN RECEPTOR; PLACE PREFERENCE; PRIORITY JOURNAL;

ALLODYNIA; HYPERALGESIA; MONOIODOACETATE; OSTEOARTHRITIS; PAIN; SPINAL CORD;

ANALGESICS; ANIMALS; ARTHRALGIA; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; HYPERALGESIA; OSTEOARTHRITIS, KNEE;

EID: 84882627609     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.06.013     Document Type: Article

References (92)

1. Rainbow R., Ren W., Zeng L. Inflammation and joint tissue interactions in OA: implications for potential therapeutic approaches. Arthritis 2012, 2012:741582.
2. Sofat N., Ejindu V., Kiely P. What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology (Oxford) 2011, 50:2157-2165.
3. Mutso A.A., Radzicki D., Baliki M.N., Huang L., Banisadr G., Centeno M.V., et al. Abnormalities in hippocampal functioning with persistent pain. JNeurosci 2012, 32:5747-5756.
4. Hochberg M.C., Hunter D.J., Felson D.T. Osteoarthritis. Br Med J 2006, 332:640-642.
5. Fernihough J., Gentry C., Malcangio M., Fox A., Rediske J., Pellas T., et al. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 2004, 112:83-93.
6. Bove S.E., Laemont K.D., Brooker R.M., Osborn M.N., Sanchez B.M., Guzman R.E., et al. Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia. Osteoarthr Cartil 2006, 14:1041-1048.
7. Inglis J.J., McNamee K.E., Chia S.-L., Essex D., Feldmann M., Williams R.O., et al. Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arthritis Rheum 2008, 58:3110-3119.
8. Marker C.L., Pomonis J.D. The monosodium iodoacetate model of osteoarthritis pain in the rat. Methods Mol Biol 2012, 851.
9. Kobayashi K., Imaizumi R., Sumichika H., Tanaka H., Goda M., Fukunari A., et al. Sodium iodoacetate-induced experimental osteoarthritis and associated pain model in rats. JVet Med Sci 2003, 65:1195-1199.
10. Guzman R.E., Evans M.G., Bove S., Morenko B., Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 2003, 31:619-624.
11. Piscaer T.M., Waarsing J.H., Kops N., Pavljasevic P., Verhaar J.A., van Osch G.J., et al. Invivo imaging of cartilage degeneration using microCT-arthrography. Osteoarthr Cartil 2008, 16:1011-1017.
12. Chandran P., Pai M., Blomme E.A., Hsieh G.C., Decker M.W., Honore P. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. Eur J Pharmacol 2009, 613:39-45.
13. Vonsy J.L., Ghandehari J., Dickenson A.H. Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats. Eur J Pain 2009, 13:786-793.
14. D'Souza W.N., Ng G.Y., Youngblood B.D., Tsuji W., Lehto S.G. Areview of current animal models of osteoarthritis pain. Curr Pharm Biotechnol 2011, 12:1596-1612.
15. Little C.B., Zaki S. What constitutes an "animal model of osteoarthritis"-the need for consensus?. Osteoarthr Cartil 2012, 20:261-267.
16. Janusz M.J., Bendele A.M., Brown K.K., Taiwo Y.O., Hsieh L., Heitmeyer S.A. Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor. Osteoarthr Cartil 2002, 10:785-791.
17. Henry J.L. Molecular events of chronic pain: from neuron to whole animal in an animal model of osteoarthritis. Novartis Found Symp 2004, 260:139-145. discussion 145-153, 277-139.
18. Ferland C.E., Laverty S., Beaudry F., Vachon P. Gait analysis and pain response of two rodent models of osteoarthritis. Pharmacol Biochem Behav 2011, 97:603-610.
19. Knights C.B., Gentry C., Bevan S. Partial medial meniscectomy produces osteoarthritis pain-related behaviour in female C57BL/6 mice. Pain 2012, 153:281-292.
20. Fenty M.C., Dodge G.R., Kassey V.B., Witschey W.R., Borthakur A., R R. Quantitative cartilage degeneration associated with spontaneous osteoarthritis in a guinea pig model. JMagn Reson Imaging 2012, 35:891-898.
21. Stevenson G.W., Mercer H., Cormier J., Dunbar C., Benoit L., Adams C., et al. Monosodium iodoacetate-induced osteoarthritis produces pain-depressed wheel running in rats: implications for preclinical behavioral assessment of chronic pain. Pharmacol Biochem Behav 2011, 98:35-42.
22. Liu P., Okun A., Ren J., Guo R.C., Ossipov M.H., Xie J., et al. Ongoing pain in the MIA model of osteoarthritis. Neurosci Lett 2011, 493:72-75.
23. Okun A., Liu P., Davis P., Ren J., Remeniuk B., Brion T., et al. Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain 2012, 153:924-933.
24. Embree M.C., Kilts T.M., Ono M., Inkson C.A., Syed-Picard F., Karsdal M.A., et al. Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis. Am J Pathol 2010, 176:812-826.
25. Wadhwa S., Embree M., Ameye L., Young M. Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis. Cells Tissues Organs 2005, 181:136-143.
26. Roemer F.W., Kassim J.M., Guermazi A., Thomas M., Kiran A., Keen R., et al. Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI. Osteoarthr Cartil 2010, 18:1269-1274.
27. Hill C.L., Hunter D.J., Niu J., Clancy M., Guermazi A., Genant H., et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007, 66:1599-1603.
28. Scanzello C.R., Goldring S.R. The role of synovitis in osteoarthritis pathogenesis. Bone 2012, 51:249-257.
29. Orita S., Ishikawa T., Miyagi M., Ochiai N., Inoue G., Eguchi Y., et al. Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord 2011, 12:134.
30. Orita S., Ishikawa T., Miyagi M., Ochiai N., Inoue G., Eguchi Y., et al. Percutaneously absorbed NSAIDs attenuate local production of proinflammatory cytokines and suppress the expression of c-Fos in the spinal cord of a rodent model of knee osteoarthritis. JOrthop Sci 2012, 17:77-86.
31. Richter F., Natura G., Löser S., Schmidt K., Viisanen H., Schaible H.-G. Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats. Arthritis Rheum 2010, 62:3806-3814.
32. Özaktay A.C., Kallakuri S., Takebayashi T., Cavanaugh J., Asik I., DeLeo J., et al. Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J 2006, 15:1529-1537.
33. Kelly S., Dunham J.P., Murray F., Read S., Donaldson L.F., Lawson S.N. Spontaneous firing in C-fibers and increased mechanical sensitivity in A-fibers of knee joint-associated mechanoreceptive primary afferent neurones during MIA-induced osteoarthritis in the rat. Osteoarthr Cartil 2010, 20:305-313.
34. Schuelert N., McDougall J.J. Cannabinoid-mediated antinociception is enhanced in rat osteoarthritic knees. Arthritis Rheum 2008, 58:145-153.
35. Schuelert N., McDougall J.J. Grading of monosodium iodoacetate-induced osteoarthritis reveals a concentration-dependent sensitization of nociceptors in the knee joint of the rat. Neurosci Lett 2009, 465:184-188.
36. von Banchet G.S., Kiehl M., Schaible H.G. Acute and long-term effects of IL-6 on cultured dorsal root ganglion neurones from adult rat. JNeurochem 2005, 94:238-248.
37. Schaible H.G., von Banchet G.S., Boettger M.K., Bräuer R., Gajda M., Richter F., et al. The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci 2010, 1193:60-69.
38. Santangelo K.S., Pieczarka E.M., Nuovo G.J., Weisbrode S.E., Bertone A.L. Temporal expression and tissue distribution of interleukin-1β in two strains of guinea pigs with varying propensity for spontaneous knee osteoarthritis. Osteoarthr Cartil 2011, 19:439-448.
39. Stemkowski P.L., Smith P.A. Long-term IL-1β exposure causes subpopulation-dependent alterations in rat dorsal root ganglion neuron excitability. JNeurophysiol 2012, 107:1586-1597.
40. Schuelert N., Johnson M.P., Oskins J.L., Jassal K., Chambers M.G., McDougall J.J. Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis. Pain 2011, 152:975-981.
41. Malemud C.J. Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging 2010, 27:95-115.
42. Pinto L.G., Cunha T.M., Vieira S.M., Lemos H.P., Verri W.A., Cunha F.Q., et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 2010, 148:247-256.
43. Richter F., Natura G., Ebbinghaus M., von Banchet G.S., Hensellek S., König C., et al. Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents. Arthritis Rheum 2012, 64:4125-4134.
44. Smith M.D., Triantafillou S., Parker A., Youssef P.P., Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. JRheumatol 1997, 24:365-371.
45. Bondeson J., Wainwright S.D., Lauder S., Amos N., Hughes C.E. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 2006, 8:R187.
46. Li X., Kim J.-S., Wijnen A., Im H.-J. Osteoarthritic tissues modulate functional properties of sensory neurons associated with symptomatic OA pain. Mol Biol Rep 2011, 38:5335-5339.
47. Jotanovic Z., Mihelic R., Sestan B., Dembic Z. Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review. Drugs Aging 2012, 29:343-358.
48. Sutton S., Clutterbuck A., Harris P., Gent T., Freeman S., Foster N., et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J 2009, 179:10-24.
49. Schuelert N., McDougall J.J. Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis. Osteoarthr Cartil 2006, 14:1155-1162.
50. McDougall J.J., Watkins L., Li Z. Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis. Pain 2006, 123:98-105.
51. Schuelert N., Zhang C., Mogg A.J., Broad L.M., Hepburn D.L., Nisenbaum E.S., et al. Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain. Osteoarthr Cartil 2010, 18:1536-1543.
52. Burrage P.S., Mix K.S., Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543.
53. Mapp P.I., Walsh D.A., Bowyer J., Maciewicz R.A. Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis. Osteoarthr Cartil 2010, 18:593-600.
54. Baragi V.M., Becher G., Bendele A.M., Biesinger R., Bluhm H., Boer J., et al. Anew class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum 2009, 60:2008-2018.
55. Ahmed A.S., Li J., Erlandsson-Harris H., Stark A., Bakalkin G., Ahmed M. Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis. Pain 2012, 153:18-26.
56. Fitzpatrick L.R., Green C., Maines L.W., Smith C.D. Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2. Pharmacology 2011, 87:135-143.
57. Takeshita N., Yoshimi E., Hatori C., Kumakura F., Seki N., Shimizu Y. Alleviating effects of AS1892802, a Rho kinase inhibitor, on osteoarthritic disorders in rodents. JPharmacol Sci 2011, 115:481-489.
58. Yoshimi E., Kumakura F., Hatori C., Hamachi E., Iwashita A., Ishii N., et al. Antinociceptive effects of AS1892802, a novel Rho kinase inhibitor, in rat models of inflammatory and noninflammatory arthritis. JPharmacol Exp Ther 2010, 334:955-963.
59. Cialdai C., Giuliani S., Valenti C., Tramontana M., Maggi C.A. Effect ofintra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats. JPharmacol Exp Ther 2009, 331:1025-1032.
60. Zhu C.Z., Chin C.-l., Rustay N.R., Zhong C., Mikusa J., Chandran P., et al. Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats. Biochem Pharmacol 2011, 82:967-976.
61. Naito Y., Yoshikawa T., Tanigawa T., Sakurai K., Yamasaki K., Uchida M., et al. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic Biol Med 1995, 18:117-123.
62. Moon S.J., Woo Y.J., Jeong J.H., Park M.K., Oh H.J., Park J.S., et al. Rebamipide attenuates pain severity and cartilage degeneration in a rat model of osteoarthritis by downregulating oxidative damage and catabolic activity in chondrocytes. Osteoarthr Cartil 2012, 20:1426-1438.
63. Castro R.R., Cunha F.Q., Silva F.S.J., Rocha F.A. Aquantitative approach to measure joint pain in experimental osteoarthritis-evidence of a role for nitric oxide. Osteoarthr Cartil 2006, 14:769-776.
64. Strassle B.W., Mark L., Leventhal L., Piesla M.J., Jian L.X., Kennedy J.D., et al. Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease. Osteoarthr Cartil 2010, 18:1319-1328.
65. McDougall J.J., Schuelert N., Bowyer J. Cathepsin K inhibition reduces CTXII levels and joint pain in the guinea pig model of spontaneous osteoarthritis. Osteoarthr Carti 2010, 18:1355-1357.
66. Schaible H.G. Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep 2012, 14:549-556.
67. Appleton C.T., Pitelka V., Henry J., Beier F. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum 2007, 56:1854-1868.
68. Sagar D.R., Burston J.J., Hathway G.J., Woodhams S.G., Pearson R.G., Bennett A.J., et al. The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain. Mol Pain 2011, 7:88.
69. Lee Y., Pai M., Brederson J.D., Wilcox D., Hsieh G., Jarvis M.F., et al. Monosodium iodoacetate-induced joint pain is associated with increased phosphorylation of mitogen activated protein kinases in the rat spinal cord. Mol Pain 2011, 7:39.
70. Im H.-J., Kim J.-S., Li X., Kotwal N., Sumner D.R., van Wijnen A.J., et al. Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum 2010, 62:2995-3005.
71. Li X., Gibson G., Kim J.-S., Kroin J., Xu S., van Wijnen A.J., et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 2011, 480:34-41.
72. Miller R.E., Tran P.B., Das R., Ghoreishi-Haack N., Ren D., Miller R.J., et al. CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis. Proc Natl Acad Sci USA 2012, 109:20602-20627.
73. Sagar D.R., Staniaszek L.E., Okine B.N., Woodhams S., Norris L.M., Pearson R.G., et al. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain. Arthritis Rheum 2010, 62:3666-3676.
74. Fernihough J., Gentry C., Bevan S., Winter J. Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci Lett 2005, 388:75-80.
75. Puttfarcken P.S., Han P., Joshi S.K., Neelands T.R., Gauvin D.M., Baker S.J., et al. A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model. Pain 2010, 150:319-326.
76. Chu K.L., Chandran P., Joshi S.K., Jarvis M.F., Kym P.R., McGaraughty S. TRPV1-related modulation of spinal neuronal activity and behavior in a rat model of osteoarthritic pain. Brain Res 2011, 1369:158-166.
77. Kalff K.-M., El Mouedden M., van Egmond J., Veening J., Joosten L., Scheffer G.J., et al. Pre-treatment with capsaicin in a rat osteoarthritis model reduces the symptoms of pain and bone damage induced by monosodium iodoacetate. Eur J Pharmacol 2010, 641:108-113.
78. Parks E.L., Geha P.Y., Balikil M.N., Katzl J., Schnitzerl T.J., Apkarianl A.V. Brain activity for chronic knee osteoarthritis: dissociating evoked pain from spontaneous pain. Eur J Pain 2011, 15:843.e1-843.e14.
79. McGaraughty S., Chu K.L., Perner R.J., Didomenico S., Kort M.E., Kym P.R. TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Mol Pain 2010, 6:14.
80. Saxler G., Loer F., Skumavc M., Pfortner J., Hanesch U. Localization of SP- and CGRP-immunopositive nerve fibers in the hip joint of patients with painful osteoarthritis and of patients with painless failed total hip arthroplasties. Eur J Pain 2007, 11:67-74.
81. Ferland C.E., Pailleux F., Vachon P., Beaudry F. Determination of specific neuropeptides modulation time course in a rat model of osteoarthritis pain by liquid chromatography ion trap mass spectrometry. Neuropeptides 2011, 45:423-429.
82. Ferreira-Gomes J., Adães S., Sarkander J., Castro-Lopes J.M. Phenotypic alterations of neurons that innervate osteoarthritic joints in rats. Arthritis Rheum 2010, 62:3677-3685.
83. Ferland C.E., Beaudry F., Vachon P. Antinociceptive effects of eugenol evaluated in a monoiodoacetate-induced osteoarthritis rat model. Phytother Res 2012, 26:1278-1285.
84. Ogbonna A.C., Clark A.K., Gentry C., Hobbs C., Malcangio M. Pain-like behaviour and spinal changes in the monosodium iodoacetate model of osteoarthritis in C57Bl/6 mice. Eur J Pain 2013, 17:514-526.
85. Ivanavicius S.P., Ball A.D., Heapy C.G., Westwood F.R., Murray F., Read S.J. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: Increased expression of ATF-3 and pharmacological characterisation. Pain 2007, 128:272-282.
86. Thakur M., Rahman W., Hobbs C., Dickenson A.H., Bennett D.L. Characterisation of a peripheral neuropathic component of the rat monoiodoacetate model of osteoarthritis. PLoS One 2012, 7:e33730.
87. Calvo M., Bennett D.L. The mechanisms of microgliosis and pain following peripheral nerve injury. Exp Neurol 2012, 234:271-282.
88. Li A., Zhang Y., Lao L., Xin J., Ren K., Berman B.M., et al. Serotonin receptor 2A/C is involved in electroacupuncture inhibition of pain in an osteoarthritis rat model. Evid Based Complement Alternat Med 2011, 2011:619650.
89. Rahman W., Bauer C.S., Bannister K., Vonsy J.L., Dolphin A.C., Dickenson A.H. Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain. Mol Pain 2009, 5:45.
90. Upadhyay J., Baker S.J., Rajagovindan R., Hart M., Chandran P., Hooker B.A., et al. Pharmacological modulation of brain activity in a preclinical model of osteoarthritis. NeuroImage 2013, 64:341-355.
91. Rodriguez-Raecke R., Niemeier A., Ihle K., Ruether W., May A. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. JNeurosci 2009, 29:13746-13750.
92. Gear R.W., Levine J.D. Nucleus accumbens facilitates nociception. Exp Neurol 2011, 229:502-506.